<DOC>
	<DOCNO>NCT01089387</DOCNO>
	<brief_summary>Erectile dysfunction frequent adverse event radical prostatectomy prostate cancer . It consequence penile vascular damage , mainly arterial insufficiency venous leakage associate fibrosis corpus cavernous . Apoptosis penile cell , include mesenchymal cell , smooth muscle cell endothelial believe play important role pathophysiology post prostatectomy erectile dysfunction . Bone marrow mononucleated cell ( BMMNC ) contain different cell type may replace damage penile cell radical prostatectomy . These mainly : mesenchymal stem cell , endothelial progenitor cell hematopoietic stem cell . Intracavernous injection BMMNC may therefore find application treatment post prostatectomy erectile dysfunction . The aims phase I-II study test safety autologous intracavernous BMMNC injection evaluate benefit patient concern recovery natural erection . Patients penile vascular abnormality ( echo-doppler ) localize prostate cancer ( consider cure radical prostatectomy ) include study . Four different dos BMMNC test .</brief_summary>
	<brief_title>Intracavernous Bone Marrow Stem-cell Injection Post Prostatectomy Erectile Dysfunction</brief_title>
	<detailed_description>We show rat model post prostatectomy erectile dysfunction BMMNC injection replace apoptotic cavernous cell restore erectile function . In pig , injection high dose BMMNC corpus cavernosus cause side effect . Moreover , BMMNC remain injection site .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Localized prostate cancer : PSA ( Prostate Specific Antigen ) prior radical prostatectomy &lt; 10 ng/ml , histopathologic analysis prostate show prostate cancer Gleason score â‰¤ 7 , negative margin , absence effraction prostatic capsule , pT1 pT2 N0 NX . PSA=0 ng/ml 6 month radical prostatectomy . Normal erectile function prior radical prostatectomy . Penile arterial insufficiency venous leakage ( doppler ) time inclusion : PSV &lt; 25 cm/sec , PSV &gt; 25 cm/sec , EDV &gt; 5cm/sec , RI &lt; 0,75 . Non localized prostate cancer .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>radical prostatectomy</keyword>
</DOC>